PeptiDream Inc. (TYO:4587) is establishing Japan’s first contract manufacturing organization (CMO) for specialized peptides, which are attracting interest as post-peptide…...
Please subscribe to read the full story.
PeptiDream to Set up CMO for Specialized Peptides
Filed Under: Innovation, Materials, Pharma Tagged With: Asahi Kasei Pharma, Bristol-Myers Squibb, CMO, contract manufacturing organizations, Eli Lilly, Genentech, Kyorin Pharmaceutical, Novartis, PDPS, Peptide Discovery Platform System, PeptiDream, Sanofi, Shionogi, specialized peptides, Teijin Pharma
